Elevance Health (ELV) to Report Q3 Earnings: Can CEO Boudreaux Maintain Beat Streak?
Elevance Health (NYSE:ELV), led by CEO Gail Boudreaux, is set to unveil its Q3 earnings on Tuesday, October 21st, ahead of market hours. The company has a strong track record of surpassing estimates, with a 63% success rate in beating EPS estimates over the past two years.
Looking at recent trends, EPS estimates for ELV have not seen any upward revisions in the last three months, with 17 downward revisions. This results in a consensus EPS Estimate of $4.94, marking a significant 41.0% decrease year-over-year. However, revenue estimates paint a more optimistic picture. Over the past three months, there have been 5 upward revisions and only 2 downward revisions, leading to a consensus Revenue Estimate of $49.5B, an increase of 10.7% year-over-year. Historically, ELV has excelled in surpassing revenue estimates, achieving an 88% success rate over the last two years.
As Elevance Health prepares to release its Q3 earnings, investors will be keen to see if the company can maintain its impressive track record of beating estimates, particularly given the mixed signals from recent EPS and revenue revisions. The market will be watching closely to see how the company's performance aligns with expectations.
%20to%20Report%20Q3%20Earnings%3A%20Can%20CEO%20Boudreaux%20Maintain%20Beat%20Streak%3F){kind=link}